Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 1998, p. 7216-7224, Vol. 18, No. 12
Cancer Pharmacology, Dana-Farber Cancer
Institute, Harvard Medical School, Boston, Massachusetts 02115
Received 20 July 1998/Returned for modification 25 August
1998/Accepted 8 September 1998
The DF3/MUC1 mucin-like glycoprotein is highly overexpressed in
human carcinomas. Recent studies have demonstrated that the cytoplasmic
domain of MUC1 interacts with
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Interaction of Glycogen Synthase Kinase 3
with
the DF3/MUC1 Carcinoma-Associated Antigen and
-Catenin
-catenin. Here we show that MUC1
associates with glycogen synthase kinase 3
(GSK3
). GSK3
binds
directly to an STDRSPYE site in MUC1 and phosphorylates the serine
adjacent to proline. Phosphorylation of MUC1 by GSK3
decreases
binding of MUC1 to
-catenin in vitro and in vivo. GSK3
-mediated phosphorylation of MUC1 had no apparent effect on
-catenin levels or
the transcriptional coactivation function of
-catenin. The results,
however, demonstrate that MUC1 expression decreases binding of
-catenin to the E-cadherin cell adhesion molecule. Negative regulation of the
-catenin-MUC1 interaction by GSK3
is
associated with restoration of the complex between
-catenin and
E-cadherin. These findings indicate that GSK3
decreases the
interaction of MUC1 with
-catenin and that overexpression of MUC1 in
the absence of GSK3
activity inhibits formation of the
E-cadherin-
-catenin complex.
*
Corresponding author. Mailing address: Dana-Farber
Cancer Institute, 44 Binney St., Boston, MA 02115. Phone: (617)
632-3141. Fax: (617) 632-2934. E-mail:
donald_kufe{at}dfci.harvard.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|